DrugPatentWatch Database Preview

Emd Serono Company Profile

Email this page to a colleague

EMD SERONO has sixteen approved drugs.

There are nine US patents protecting EMD SERONO drugs.

There are two hundred and fifteen patent family members on EMD SERONO drugs in forty-three countries and sixty-seven supplementary protection certificates in sixteen countries.

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021765-001	Mar 25, 2004		DISCN	No	No		Start Trial				Start Trial
Emd Serono Inc	GLUCOPHAGE	metformin hydrochloride	TABLET;ORAL	020357-001	Mar 3, 1995		DISCN	Yes	No		Start Trial				Start Trial
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-004	Feb 28, 2001		RX	Yes	No	7,563,763	Start Trial	Y			Start Trial
Emd Serono Inc	MAVENCLAD	cladribine	TABLET;ORAL	022561-001	Mar 29, 2019		RX	Yes	Yes	7,888,328	Start Trial	Y			Start Trial
Emd Serono Inc	MAVENCLAD	cladribine	TABLET;ORAL	022561-001	Mar 29, 2019		RX	Yes	Yes	8,785,415	Start Trial	Y			Start Trial
Emd Serono Inc	GLUCOPHAGE XR	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021202-001	Oct 13, 2000		DISCN	Yes	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Emd Serono	GONAL-F RFF REDI-JECT	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021684-002	May 25, 2004	7,446,090	Start Trial
Emd Serono	GONAL-F	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	020378-005	Mar 26, 2004	5,767,067	Start Trial
Emd Serono Inc	GLUCOPHAGE XR	metformin hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021202-004	Apr 11, 2003	6,660,300	Start Trial
Emd Serono	GONAL-F RFF REDI-JECT	follitropin alfa/beta	INJECTABLE;SUBCUTANEOUS	021684-003	May 25, 2004	5,767,067	Start Trial
Emd Serono Inc	GEREF	sermorelin acetate	INJECTABLE;INJECTION	020443-001	Sep 26, 1997	4,703,035	Start Trial
Emd Serono Inc	CETROTIDE	cetrorelix	INJECTABLE;INJECTION	021197-001	Aug 11, 2000	7,605,121	Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Subscribe to access the full database, or Start Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1506211	C300677	Netherlands	Start Trial	PRODUCT NAME: COMBINATIE VAN DAPAGLIFLOZINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN EN METFORMINE OF EEN FARMACEITISCH AANVAARDBAAR ZOUT DAARVAN, ZOALS BESCHERMD DOOR HET BASISOCTROOI EP 1506211B1; REGISTRATION NO/DATE: EU/1/13/900 20140121
1261586	2012C/016	Belgium	Start Trial	PRODUCT NAME: UNE COMBINAISON DE PRODUITS DE SAXAGLIPTINE ET DE METFORMINE AINSI QUE TOUT SELS PHARMACEUTIQUEMENT ACCEPTABLES, DONT LES SELS DE CHLORHYDRATE DE SAXAGLIPTINE ET DE METFORMINE; AUTHORISATION NUMBER AND DATE: EU/1/11/731/001 20111128
1827461	18C1008	France	Start Trial	PRODUCT NAME: CLADRIBINE; REGISTRATION NO/DATE: EU/1/17/1212 20170824
1506211	122014000071	Germany	Start Trial	PRODUCT NAME: KOMBINATION VON DAPAGLIFLOZIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, UND METFORMIN ODER EINEM PHARMAZEUTISCH VERTRAEGLICHEN SALZ DAVON, GESCHUETZT DURCH DAS GRUNDPATENT EP 1 506 211; REGISTRATION NO/DATE: EU/1/13/900 20140116
2805723	LUC00064	Luxembourg	Start Trial	PRODUCT NAME: CLADRIBINE; AUTHORISATION NUMBER AND DATE: EU/1/17/1212 20170824
1827461	122018000021	Germany	Start Trial	PRODUCT NAME: CLADRIBIN; REGISTRATION NO/DATE: EU/1/17/1212 20170822
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.